FDA
-
PublishedOctober 28, 2024
New laws spearheaded by Sen. Susan Collins extend funding for Alzheimer’s
The effort builds on a 2011 initiative that helped lead to new treatments for the disease.
-
PublishedOctober 9, 2024
Bakery that makes Sara Lee and Entenmann’s pushes back on FDA sesame warning
A top U.S. commercial bakery is pushing back on a Food and Drug Administration warning to stop using labels that say its products contain sesame – even when they don't.
-
PublishedSeptember 5, 2024
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19.
-
PublishedAugust 22, 2024
FDA approves updated COVID-19 vaccines, shots should be available in days
While most Americans have some degree of immunity from prior infections or vaccinations or both, that protection wanes.
-
PublishedAugust 9, 2024
FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study
MDMA is the first in a series of psychedelics that are expected to be reviewed by the FDA in coming years as part of a resurgence of interesting into their therapeutic potential.
-
PublishedJuly 29, 2024
FDA issues warning over Freeport oysters
The Food and Drug Administration released a statement last Thursday cautioning food businesses against using oysters harvested from two sites located at Recompense Cove between June 19 and July 16 as they may contain Campylobacter bacteria.
-
PublishedMay 31, 2024
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
FDA scientists said it’s difficult to know how much of the improvement came from MDMA versus simply undergoing intensive therapy.
-
PublishedMay 24, 2024
Ozempic cuts risk of death from kidney disease, major study finds
Novo Nordisk, the maker of Ozempic will seek FDA approval to dramatically expand the number of patients eligible for the shots.
-
PublishedApril 29, 2024
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are reliable.